P38 MAPK Signalling Regulates Cytokine Production in IL-33 Stimulated Type 2 Innate Lymphoid Cells

Overview

Journal Sci Rep

Specialty Science

Date 2020 Feb 28

PMID 32103032

Citations 20

Authors

Tsvetana Petrova

Jelena Pesic

Katerina Pardali

Matthias Gaestel

J Simon C Arthur

Affiliations

Soon will be listed here.

Abstract

Type 2 Innate lymphoid cells (ILC2s) are implicated in helminth infections and asthma where they play a role in the production of Th2-type cytokines. ILC2s express the IL-33 receptor and are a major cell type thought to mediate the effects of this cytokine in vivo. To study the signalling pathways that mediate IL-33 induced cytokine production, a culture system was set up to obtain pure populations of ILC2s from mice. Inhibitors of the p38α/β and ERK1/2 MAPK pathways reduced the production of IL-5, IL-6, IL-9, IL-13 and GM-CSF by ILC2 in response to IL-33, with inhibition of p38 having the greatest effect. MK2 and 3 are kinases activated by p38α; MK2/3 inhibitors or knockout of MK2/3 in mice reduced the production of IL-6 and IL-13 (two cytokines implicated in asthma) but not IL-5, IL-9 or GM-CSF in response to IL-33. MK2/3 inhibition also suppressed IL-6 and IL-13 production by human ILC2s. MK2/3 were required for maximal S6 phosphorylation, suggesting an input from the p38α-MK2/3 pathway to mTOR1 activation in ILC2s. The mTORC1 inhibitor rapamycin also reduced IL-6 and IL-13 production, which would be consistent with a model in which MK2/3 regulate IL-6 and IL-13 via mTORC1 activation in ILC2s.

Citing Articles

Lung-resident lymphocytes and their roles in respiratory infections and chronic respiratory diseases.

Sen Chaudhuri A, Sun J Chin Med J Pulm Crit Care Med. 2025; 2(4):214-223.

PMID: 39834580 PMC: 11742555. DOI: 10.1016/j.pccm.2024.11.006.

Maternal asthma imprints fetal lung ILC2s via glucocorticoid signaling leading to worsened allergic airway inflammation in murine adult offspring.

Takao T, Matsui A, Kikutake C, Kan-O K, Inoue A, Suyama M Nat Commun. 2025; 16(1):631.

PMID: 39805834 PMC: 11730321. DOI: 10.1038/s41467-025-55941-8.

Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivity.

Hurrell B, Shen S, Li X, Sakano Y, Kazemi M, Quach C J Exp Med. 2024; 221(5).

PMID: 38530239 PMC: 10965393. DOI: 10.1084/jem.20231835.

A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut.

Wang Y, He C, Xin S, Liu X, Zhang S, Qiao B Int J Mol Sci. 2023; 24(17).

PMID: 37686309 PMC: 10487440. DOI: 10.3390/ijms241713504.

Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation.

Tanaka Y, Yamagishi M, Motomura Y, Kamatani T, Oguchi Y, Suzuki N Commun Biol. 2023; 6(1):915.

PMID: 37673922 PMC: 10482971. DOI: 10.1038/s42003-023-05297-w.

References

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13(2):145-9. DOI: 10.1038/nri3365. View

Simoni Y, Newell E . Dissecting human ILC heterogeneity: more than just three subsets. Immunology. 2017; 153(3):297-303. PMC: 5795188. DOI: 10.1111/imm.12862. View

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate Lymphoid Cells: 10 Years On. Cell. 2018; 174(5):1054-1066. DOI: 10.1016/j.cell.2018.07.017. View

Wang S, Xia P, Chen Y, Qu Y, Xiong Z, Ye B . Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation. Cell. 2017; 171(1):201-216.e18. DOI: 10.1016/j.cell.2017.07.027. View

Fallon P, Ballantyne S, Mangan N, Barlow J, Dasvarma A, Hewett D . Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006; 203(4):1105-16. PMC: 2118283. DOI: 10.1084/jem.20051615. View

Walker J, McKenzie A . Development and function of group 2 innate lymphoid cells. Curr Opin Immunol. 2013; 25(2):148-55. PMC: 3776222. DOI: 10.1016/j.coi.2013.02.010. View

Klose C, Artis D . Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol. 2016; 17(7):765-74. DOI: 10.1038/ni.3489. View

Moro K, Ealey K, Kabata H, Koyasu S . Isolation and analysis of group 2 innate lymphoid cells in mice. Nat Protoc. 2015; 10(5):792-806. DOI: 10.1038/nprot.2015.047. View

Barlow J, Peel S, Fox J, Panova V, Hardman C, Camelo A . IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol. 2013; 132(4):933-41. DOI: 10.1016/j.jaci.2013.05.012. View

10.

Bartemes K, Kephart G, Fox S, Kita H . Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014; 134(3):671-678.e4. PMC: 4149890. DOI: 10.1016/j.jaci.2014.06.024. View

11.

Moussion C, Ortega N, Girard J . The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS One. 2008; 3(10):e3331. PMC: 2556082. DOI: 10.1371/journal.pone.0003331. View

12.

Arshad M, Patrat-Delon S, Piquet-Pellorce C, LHelgoualch A, Rauch M, Genet V . Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis. PLoS One. 2013; 8(9):e74278. PMC: 3772926. DOI: 10.1371/journal.pone.0074278. View

13.

Martin N, Martin M . Interleukin 33 is a guardian of barriers and a local alarmin. Nat Immunol. 2016; 17(2):122-31. DOI: 10.1038/ni.3370. View

14.

Liew F, Pitman N, McInnes I . Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010; 10(2):103-10. DOI: 10.1038/nri2692. View

15.

Lohning M, Stroehmann A, Coyle A, Grogan J, Lin S, Gutierrez-Ramos J . T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A. 1998; 95(12):6930-5. PMC: 22690. DOI: 10.1073/pnas.95.12.6930. View

16.

Lingel A, Weiss T, Niebuhr M, Pan B, Appleton B, Wiesmann C . Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes. Structure. 2009; 17(10):1398-410. PMC: 2766095. DOI: 10.1016/j.str.2009.08.009. View

17.

Kroeger K, Sullivan B, Locksley R . IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. J Leukoc Biol. 2009; 86(4):769-78. PMC: 2752018. DOI: 10.1189/jlb.0708452. View

18.

Cohen P . The TLR and IL-1 signalling network at a glance. J Cell Sci. 2014; 127(Pt 11):2383-90. PMC: 4038938. DOI: 10.1242/jcs.149831. View

19.

Arthur J, Ley S . Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013; 13(9):679-92. DOI: 10.1038/nri3495. View

20.

Lomaga M, Yeh W, Sarosi I, Duncan G, Furlonger C, Ho A . TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999; 13(8):1015-24. PMC: 316636. DOI: 10.1101/gad.13.8.1015. View